KR20240030111A - Formulation outputting apparatus and formulation dispenser having the same - Google Patents

Abstract

The present invention relates to a formulation dispensing device, wherein the formulation is positioned in an internal storage space and includes a formulation cartridge having a first coupling portion, and a formulation discharging unit coupled to the first coupling portion of the formulation cartridge. , the formulation discharge unit has a second coupling portion coupled to the first coupling portion, a rotor portion coupling groove and a discharge portion coupling groove sequentially located at the bottom, and a first direction on the lower inner surface of the second coupling portion. A unit main body having a first direction protrusion extending in parallel, a rotor unit that is mounted on and rotates in the rotor unit coupling groove and has a plurality of seating holes, and a rotor unit that is mounted in the discharge unit coupling groove and rotates. It is located at the bottom and includes a discharge portion having a discharge port through which the formulation is discharged.

Description

Formulation dispensing device and formulation dispenser equipped with the same {FORMULATION OUTPUTTING APPARATUS AND FORMULATION DISPENSER HAVING THE SAME}

The present invention relates to a formulation dispensing device and a formulation dispenser equipped therewith.

Nutrients containing trace elements (zinc, iron, magnesium, etc.) or vitamins are generally recognized as health supplements that supplement the human body.

However, these nutrients may be used as treatments when necessary, and when used as treatments, the dosage may be strictly limited depending on the patient's condition.

For example, patients with osteomalacia must be prescribed vitamin D, and the dosage is determined according to the calcium concentration in the blood. At this time, if a patient with osteomalacia takes excessive amounts of vitamin D, side effects such as calcium stones or hypertensive disease may occur.

In addition, isoniazid, which is used to treat tuberculosis, can rapidly consume niacin (nicotinic acid) contained in the patient's blood during tuberculosis treatment. Therefore, if niacin deficiency occurs, the doctor must determine whether the niacin in the patient's blood is Determine the appropriate dose of isoniazid for the patient based on the concentration.

Likewise, nutritional supplements taken for health have the risk of acting as drugs that harm health if taken incorrectly depending on each user's physical condition such as underlying disease, so it is important to take the necessary amount of the type needed for the body.

In this way, it is best to take dosage forms such as health supplements or nutritional supplements or pills taken for treatment purposes at an appropriate dose at a designated time according to the user's physical condition.

However, it is difficult to take exactly the type of dosage form that is right for the user.

In particular, when taking a formulation as a health supplement, such as an aphrodisiac, unlike in the case of a disease, it does not directly affect the current health of the body, so the user can choose the product at their own discretion instead of a prescription from a specialist such as a pharmacist or doctor. There are many cases of taking it, and it is even more difficult to take the dosage form consistently in an accurate manner.

US published patent US2015/0090733 A1 (Device for Dispensing Pharmaceutical Doses) Korean Patent Publication No. 10-2015-0014269 (Tablet medicine dispensing device) US published patent US2006/0213921 A1 (PILL DISPENSING APPARATUS)

The problem to be solved by the present invention is to simplify the structure of a formulation dispensing device that automatically discharges the formulation.

A formulation dispensing device according to an aspect of the present invention includes a formulation cartridge having a first coupling portion in which a formulation is located in an internal storage space, and a formulation discharging unit coupled to the first coupling portion of the formulation cartridge, and discharging the formulation. The unit has a second coupling portion coupled to the first coupling portion, a rotor portion coupling groove and a discharge portion coupling groove sequentially located at the bottom, and extending in parallel in the first direction from the lower inner surface of the second coupling portion. A unit body having a first direction protrusion, a rotor unit that is mounted on and rotates in the rotor unit coupling groove and has a plurality of seating holes, and is mounted in the discharge unit coupling groove and is located below the rotor unit, It includes a discharge portion having a discharge port through which the formulation is discharged.

The gap between the first direction protrusion and the upper surface of the rotor unit facing the first direction protrusion at the bottom may be less than or equal to the minimum diameter and minimum height of the dosage form.

The first direction protrusion may overlap by more than 1/2 of the diameter of the seating hole located at the bottom.

The width of the first direction protrusion may increase toward the discharge hole.

The first direction protrusion may overlap the discharge port located below.

The rotor unit may further include a rotor cone located in the center and surrounded by the seating port.

The unit body may further include a second direction protrusion protruding from a lower surface of the second coupling portion in a second direction intersecting the first direction.

The rotor unit is located between two adjacent seating holes and may further include a second direction protrusion insertion groove into which the second direction protrusion is inserted.

The width of the second direction protrusion insertion groove may be greater than the width of the second direction protrusion and smaller than the maximum width of the seating hole.

The discharge unit may further include a guide surface connected to the discharge port and inclined toward the discharge port.

The second direction protrusion may overlap the guide surface and the discharge port located below.

The protrusion length of the second direction protrusion may increase toward the discharge hole.

The position of the guide surface may overlap the position of the second direction protrusion in the second direction.

The inclination direction of the guide surface may be parallel to the inclination direction of the lower end of the second direction protrusion.

A formulation dispenser according to another aspect of the present invention includes a formulation dispensing device having at least one of the above-described features.

The formulation dispenser according to the above characteristics includes a driving unit connected to the formulation dispensing device, a control unit connected to the driving unit and operating the driving unit, and a memory connected to the control unit and storing data necessary for operation of the control unit. It may further include.

According to these characteristics, the dispensing operation of the formulation can be performed stably and smoothly using a simple structure.

1 is a perspective view of a formulation dispensing device according to an embodiment of the present invention.
FIG. 2 is a cross-sectional view obtained when the formulation ejection device shown in FIG. 1 is cut in one direction.
Figures 3 and 4 are exploded perspective views of a formulation dispensing device according to an embodiment of the present invention, taken from different directions.
FIGS. 5A to 5C are views of the unit body of the formulation dispensing device according to an embodiment of the present invention. FIG. 5A is a plan view, 5B is a cross-sectional view obtained when cutting along one direction, and FIG. 5C is a view in one direction. This is the obtained perspective view.
FIG. 6A is a perspective view obtained from one direction of the formulation ejection unit of the formulation ejection device according to an embodiment of the present invention, and FIG. 6b is a cross-sectional view obtained by cutting FIG. 6A along the line VI-VI.
Figure 7 is a cross-sectional view obtained when the formulation ejection unit of the formulation ejection device according to an embodiment of the present invention is cut in one direction.
FIGS. 8A to 8D are views of the rotor part of the formulation dispensing device according to an embodiment of the present invention. FIGS. 8A and 8B are perspective views obtained from different directions, FIG. 8C is a top view, and FIG. 8D is a view in one direction. This is a cross-sectional view obtained when cutting along .
Figure 9a is a cross-sectional view obtained when cutting the formulation discharge unit of the formulation discharge device according to an embodiment of the present invention along one direction.
Figure 9b is a cross-sectional view obtained when the rotor part is omitted and cut along one direction in the formulation discharge unit of the formulation discharge device according to an embodiment of the present invention.
Figure 10 is a schematic block diagram of a formulation dispenser according to an embodiment of the present invention.

Hereinafter, embodiments disclosed in the present specification will be described in detail with reference to the attached drawings. However, identical or similar components will be assigned the same reference numbers regardless of reference numerals, and duplicate descriptions thereof will be omitted. Additionally, in describing the embodiments disclosed in this specification, if it is determined that detailed descriptions of related known technologies may obscure the gist of the embodiments disclosed in this specification, the detailed descriptions will be omitted.

Terms containing ordinal numbers, such as first, second, etc., may be used to describe various components, but the components are not limited by the terms. The above terms are used only for the purpose of distinguishing one component from another.

Singular expressions include plural expressions unless the context clearly dictates otherwise.

In this application, each step described may be performed regardless of the listed order, except when it must be performed in the listed order due to a special causal relationship.

In this application, terms such as “comprise” or “have” are intended to designate the presence of features, numbers, steps, operations, components, parts, or combinations thereof described in the specification, but are not intended to indicate the presence of one or more other features. It should be understood that this does not exclude in advance the possibility of the existence or addition of elements, numbers, steps, operations, components, parts, or combinations thereof.

Hereinafter, a formulation dispensing device and a formulation dispenser equipped therewith according to an embodiment of the present invention will be described with reference to the attached drawings.

In this specification, a dosage form refers to a solid form of a health supplement such as a nutritional supplement or a medicine according to the purpose or purpose of use, and the shape of the dosage form may have various shapes such as circular, oval, cylindrical, polygonal, etc.

First, with reference to FIGS. 1 to 9, the formulation dispensing device 100 according to an embodiment of the present invention will be described.

The formulation dispensing device 100 according to this example may include a formulation cartridge 1 and a formulation dispensing unit 2 coupled to the formulation cartridge 1.

The formulation cartridge 1 is a part where the formulation to be discharged to the outside through the formulation discharge unit 2 is located, and the cartridge body 11 and the coupling portion (e.g., the first coupling portion) located at the end of the cartridge body 11. )(12) can be provided.

The cartridge body 11 is a part where the formulation to be discharged to the outside is stored. The lower part is open and the upper and side parts are surrounded by the upper and side surfaces, so that it can be provided with a storage space (S11) where the formulation is located inside. there is.

This cartridge body 11 may have various shapes, such as a cylindrical shape with an open bottom or a polygonal pillar shape such as a triangular pillar.

The first coupling portion 12 located at the end of the cartridge body 11 may have a screw groove and a screw thread located on the outside of the side and may be a portion for screw coupling with the formulation dispensing unit 2.

The formulation discharge unit 2 has a unit body 20 coupled to the first coupling portion 12, which is a coupling portion of the formulation cartridge 1, and is located at the lower part of the unit body 20 and has at least one seating port 32. It may be provided with a rotor unit 30 and a discharge unit 40 located below the rotor unit 30 and having a guide surface 411 and a discharge port H42.

At the lower part of the rotor unit 30, a rotation shaft unit 50 may be provided that penetrates the discharge unit 40 and is coupled to the rotor unit 30. The rotation shaft unit 50 is used to rotate the rotor unit 30, and one side may be fixedly coupled to a driving unit (not shown), and the other side may be coupled to the rotor unit 30.

The unit body 20 has a case 21 that is open at the top and bottom, and the sides are surrounded by sides. A coupling part located inside the case 21 is open at the top and bottom and has a circular planar shape. (e.g., a second coupling portion) 22, an inner wall 221 located in a space surrounded by the second coupling portion 22, and a first coupling portion located on the inner surface of the inner wall 221 and extending in the first direction. It may be provided with a direction protrusion 23 and a second direction protrusion 24 extending in a second direction intersecting the first direction.

The case 21 may have a planar shape that is the same as or similar to that of the formulation cartridge 1, and may have a function of protecting the second coupling portion 22 located therein.

At the lower part of the case 21, a rotor part coupling groove (R21) and a discharge part coupling groove (R22), where the rotor part 30 and the discharge part 40 are located, are located sequentially.

Since the diameter of the rotor coupling groove (R21) located on the upper side of the rotor coupling groove (R21) and the discharge coupling groove (R22) is smaller than the diameter of the discharge coupling groove (R22), the rotor coupling groove (R21) is located at the upper part of the rotor coupling groove (R21) and the discharge coupling groove (R22). It may have a stepped structure in which the coupling groove (R21) and the discharge portion coupling groove (R22) are positioned sequentially.

A plurality of coupling holes (H22) may be located in the discharge unit coupling groove (R22) to stably maintain the coupling state with the discharge unit (40).

The second coupling portion 22 is located in an internal space surrounded by the case 21, has open upper and lower sides, and has side surfaces having a circular planar shape.

The inside of the side of the second coupling part 22 may be provided with a screw groove and thread for coupling with the first coupling part 12.

Therefore, the second coupling part 22 is screwed to the first coupling part 12 so that the formulation located in the storage space S11 of the formulation cartridge 1 is placed in a seating space that is the inner space of the second coupling part 22. (S20) You can descend and move inside.

In this way, the formulation that has moved from the formulation cartridge 1 to the seating space S20 of the second coupling portion 22 of the formulation discharge unit 2 is discharged through the discharge portion 40 according to the rotational motion of the rotor portion 30. It can be discharged to the outside through.

As already described, the inner wall 221 is located in an empty space surrounded by the circular second coupling portion 22 and may be a side wall having a circular planar shape.

The upper end of the inner wall 221 may be positioned in contact with the lower end of the formulation cartridge 1, that is, the lower end of the first coupling portion 12, as shown in FIG. 2.

Accordingly, the formulation located in the formulation cartridge 1 can flow into the inner space surrounded by the inner wall 221, and the inner space surrounded by the inner wall 221 can become a substantial seating space S20.

The first direction protrusion 23 prevents damage to the plurality of formulations located in the seating space S20 of the inner wall 221 and can operate to move one by one to the discharge port H42 of the rotor unit 30.

In this example, this first direction protrusion 23 is. As shown in FIG. 5A, it may protrude from the inner side of the inner wall 221 in a first direction toward the seating space S20, and may extend circularly along the inner periphery of the inner side of the inner wall 221. You can.

The first direction protrusion 23 protruding from the inner surface of the inner wall 221 toward the inner seating space S20 may be positioned to overlap the discharge port H42 located below in the vertical direction.

In addition, the first direction protrusion 23 may overlap each seating port 32 of the rotor unit 30 located at the lower portion, as shown in FIGS. 6A and 6B. For example, each seating port 32 located at the lower portion It may overlap by more than 1/2 of the diameter of the sphere 32. In order to overlap with the seating port 32, the first direction protrusion 23 allows only one formulation located at the seating port 32 to move toward the discharge port H42, allowing the formulations to fall one by one from the discharge port H42. Let it happen.

The widths (W1, W2) of the first direction protrusion 23 may be different depending on the location, and as shown in FIG. 5A, for example, the first direction protrusion 23 extends along the inner surface of the inner wall 221. Since the width may increase as it extends toward the discharge port H42, the width of the first direction protrusion 23 may increase toward the discharge portion 40.

Therefore, the width W1 of the end e11 furthest from the discharge port H42 at both ends e11 and e12 of the first direction protrusion 23 extending along the inner surface of the first coupling portion 12. ) is the narrowest, and the width (W2) of the end (e12) closest to the discharge port (H42) may be the widest.

As a result, it is possible to prevent or reduce the problem of damage caused by the formulation moving along the rotational direction of the rotor unit 30 colliding with the end e11 of the first direction protrusion 23.

In addition, as shown in FIG. 7, the first direction protrusion 23 and the second direction protrusion 24 are located in contact with or adjacent to the corresponding portion of the rotor unit 30 located at the lower portion, so that these protrusions 23, 24) and the corresponding rotor unit 30, there may not be a space for the formulation to be inserted.

Accordingly, the formulation located in the seating port 32 can be stably positioned within the seating port 32 without fear of being separated and rotated according to the rotational motion of the rotor unit 30.

Accordingly, when the dosage form is normally located in the seating port 32 and one or more dosage forms exist on or around the dosage form, the seating port 32 according to the rotational motion of the rotor unit 30 due to the first direction protrusion 23. ) Only the dosage form that is normally located can move toward the discharge port (H42) by rotating in that direction.

As a result, when the rotor unit 30 rotates, only the formulation normally located in the seating port 32 among the formulations located in the seating space S20 moves toward the discharge port H42, and thus moves toward the discharge port H42. When the discharging operation of the formulation is performed, only one formulation can be discharged at a time, and damage to the formulation due to the first direction protrusion 23 can also be prevented.

As shown in FIG. 7, the second direction protrusion 24 may be spaced apart from the inner wall 221 and positioned adjacent to the end of the first direction protrusion 23, and may be located at the lower portion of the first direction protrusion 23. It may be drawn toward the discharge port H42 in a downward direction (e.g., second direction) from the surface.

Accordingly, the second direction protrusion 24 may extend along the bottom of the curved inner wall 221, and thus the second direction protrusion 24 may also extend long along the inner periphery of the inner wall 221.

The downward protruding length of the second direction protrusion 24 may vary depending on the location and may increase toward the discharge port H42 of the discharge portion 40, so that the lower portion of the second direction protrusion 24 The surface may have a slope that slopes upward toward the opposite side of the discharge port (H42).

The maximum extended length of the second direction protrusion 24 may be determined depending on the size of the dosage form.

In this example, the second direction protrusion 24 may be located only on a portion of the first direction protrusions 23, and for example, may be located on only approximately half of the total first direction protrusions 23.

In addition, the second direction protrusion 24 is located at the bottom and may be positioned to overlap the guide surface 411, which is an inclined surface of the discharge unit 40, and the discharge port H42, and the guide surface 411 is inclined toward the discharge port H42. As the inclination angle of ) increases, the protrusion length of the second direction protrusion 24 may also be proportional.

This second direction protrusion 24 can apply pressure from the upper part of the formulation moving toward the discharge port H42, and due to this pressure application, the rotational movement of the rotor unit 30 becomes more stable. This ensures that the formulation moves safely and accurately toward the discharge port (H42).

The rotor unit 30 is for discharging the formulation to the outside through a rotational movement, and rotates in a predetermined direction between the unit body 20 and the discharge unit 40, which is a stationary body with a fixed position without rotating movement. It may be a rotating body that performs

This rotor unit 30 is located in the rotor unit coupling groove (R21) located at the lower part of the case 21 and can be rotatably positioned at the lower part of the case 21.

Therefore, since the lower part of the seating space (S20) located within the inner wall 221 may be blocked by the rotor unit 30, the seating space (S20) connected to the storage space (S11) of the formulation cartridge (1) is It may be blocked by the inner wall 221 and the rotor unit 30.

The rotor unit 30 rotates within the rotor unit coupling groove R21 to perform a dispersion operation of the plurality of formulations located in the seating space S20, so that the plurality of formulations are smoothly discharged one by one through the discharge unit 40 without clumping. make it possible

This rotor unit 30 may have a circular planar shape, as shown in FIGS. 3, 4, and 6A to 8D, and has a rotor cone in the center that protrudes upward, that is, toward the formulation cartridge 1. A rotor unit main body 31 having an edge 312 positioned to surround the rotor cone 311 in a circular shape, and a plurality of seating holes arranged to be spaced apart in a circle along the edge 312. (32) and a plurality of second direction protrusion insertion grooves (33) located between two adjacent seating holes (32).

In this example, the rotational speed of the rotor unit 30 may be determined by considering the separation distance between the seating ports 32.

As already described, the rotor cone 311 may be located in the center of the rotor unit 30, and may be inclined downward from the center outward.

Therefore, as shown in FIG. 8A, the rotor cone 311 may have a cone shape that protrudes upward toward where the formulation cartridge 1 is located, and has an upper portion adjacent to the second coupling portion 22. The surface may be a flat inclined surface.

This rotor cone 311 allows the plurality of formulations T10 located in the seating space S20 to move toward the edge 312 of the rotor unit 30 where the plurality of seating holes 32 are located.

As shown in FIG. 8B, the lower part of the rotor cone 311 has a cone shape and is open downward, and a coupling space S311 for coupling with the rotating shaft portion 50 may exist.

A shaft coupling portion (eg, first shaft coupling portion) 34 for coupling to the rotating shaft portion 50 may be located within this coupling space (S311).

The first shaft coupling portion 34 is located on the inside of the lower surface of the rotor cone 311 and has a side wall 341 having a circular planar shape and a plurality of shaft coupling protrusions ( For example, it may be provided with a first shaft coupling protrusion (342).

The plurality of first shaft coupling protrusions 342 may have the same size and shape, and as shown in FIG. 4, may extend long along the vertical direction from each corresponding portion of the side wall 341. Accordingly, a portion of the side wall 341 on which the first shaft coupling protrusion 342 is not located may be exposed between two adjacent first shaft coupling protrusions 342 .

By this first shaft coupling portion 34, the rotor portion 30 is physically and fixedly coupled to the rotation shaft portion 50, and can rotate in a desired direction and speed by the rotational force transmitted from the rotation shaft portion 50. .

A plurality of seating holes 32 arranged in a circle at the edge 312 of the rotor unit 30 with the rotor cone 311 as the center wait for discharge toward the discharge port H42 of the discharge unit 40. It may be a hole in which the dosage form is temporarily located.

Therefore, as the rotor unit 30 rotates in a predetermined direction, each seating port 32 may overlap with the discharge port H42 of the discharge unit 40, and the overlap of the seating port 32 and the discharge port H42 may occur. When this is done, the formulation (T10) located in the seating port 32 may flow into the overlapping discharge port (H42) and be discharged to the outside.

These plurality of seating holes 32 are spaced apart from each other, each has a circular planar shape, and may be a hole that completely penetrates the edge of the rotor unit 30.

As shown in FIG. 3, the edge portion 312 of the rotor unit 30 may have a flat surface, unlike the rotor cone 311, which has an inclined surface, so that the edge portion 312 is formed along the inclined surface of the rotor cone 311. The dosage form (T10) moved to the side can be easily inserted into the corresponding seating hole (32).

The diameter and depth of each seating hole 32 can be determined by considering the diameter and thickness of the formulation (T10) located in the seating space (S20), and the diameter of each seating hole (32) is one size of the formulation (T10). It may be larger than the maximum diameter, and the depth of each seating hole 32 may also be larger than the maximum thickness of the corresponding formulation (T10).

The diameter and depth of the seating hole 32 may be larger and less than about 2 times the maximum diameter and maximum thickness of one formulation (T10), for example, about 1.2 to 1.7 times.

The second direction protrusion insertion groove 33 located between the two adjacent seating ports 32 may be positioned to connect approximately the middle portions of the two adjacent seating ports 32 to each other, and unlike the seating port 32, the second direction protrusion insertion groove 33 may be located between the two adjacent seating ports 32 and the rotor portion. (30) may not be completely penetrated.

For example, the depth t1 of the second direction protrusion insertion groove 33 may be about 1/3 to 2/3 of the thickness t2 of the rotor unit 30.

The thickness t2 of the rotor unit 30 may be between 0.8 and 1.2 times the maximum width or height of the formulation T10.

As shown in FIG. 8C, the width W3 of the second direction protrusion insertion groove 33 may be larger than the width of the second direction protrusion 23 and smaller than the maximum width W4 of the seating port 32. For example, the width W3 of the second direction protrusion insertion groove 33 may be smaller than 1/2 of the maximum width W4 of the seating port 32. Alternatively, the width W3 of the second direction protrusion insertion groove 33 may be smaller than the maximum width or height of the dosage form T10.

Additionally, the maximum width (W2) of the seating port 32 may be twice or less than the maximum width of the dosage form (T10) located therein. For example, the maximum width (W2) of the seating port 32 may be greater than the maximum width or height of the dosage form (T10) and 1.5 times or less of the maximum width or height of the dosage form (T10).

The two seating holes 32 that are spaced apart from each other may be connected to each other by the second direction protrusion insertion groove 33.

If the plurality of second direction protrusion insertion grooves 33 located between these two adjacent seating holes 32 are connected with virtual lines, it can have a virtual circular plane shape.

As already described, the plurality of second direction protrusion insertion grooves 33 having a virtual circular planar shape can be inserted into the second direction protrusion 24 located on the lower surface of the first direction protrusion 23. You can. As a result, the rotor unit 30, as already described, achieves a stable rotational motion without interference from the second direction protrusion 24, and the formulation T10 located at each seating port 32 is positioned at the seating port 32. Ensure that it moves stably toward the discharge port (H42) without being separated from it.

As shown in FIG. 7, the discharge unit 40 may be located below the rotor unit 30 and may be located in the discharge unit coupling groove R22 located on the lower surface of the case 21.

As already described, since the discharge part coupling groove (R22) is located below the rotor part coupling groove (R21), the rotor part 30 rotates in a predetermined direction on the discharge part 40 and connects to the plurality of seating holes 32. An operation can be performed to discharge the positioned formulation toward the discharge port (H42) of the discharge unit (40).

As shown in FIGS. 3 and 4, this discharge unit 40 includes a circular rotating shaft insertion hole (H41) in the center, a discharge hole (H42) located at the edge, and a guide surface (411) connected to the discharge hole (H42). It may be provided with a discharge unit main body 41 and a discharge pipe 43 connected to the discharge port H42 of the discharge unit main body 41.

Located in the middle part of the discharge unit main body 41, the rotation shaft insertion hole (H41) is a part where the rotation shaft portion 50 is inserted. After the rotation shaft portion 50 is inserted through this rotation shaft insertion hole (H41), the rotor portion ( 30) can be combined.

The discharge port H42 may be a hole that discharges one formulation into the discharge pipe 43. This discharge port (H42) may be located in a portion of the discharge unit main body 41 as shown in FIG. 3.

As already described, as shown in FIG. 9A, the discharge port H42 may be positioned to overlap the first direction protrusion 23 and the second direction protrusion 24 located on the upper rotor unit 30.

As shown in FIG. 9B, the overlapping length of the discharge unit main body 41 of the first direction protrusion 23 may be longer than that of the second direction protrusion 24.

As an example, the second direction protrusion 24 extends from the start of the guide surface 411 (i.e., the part with the smallest angle of the inclined surface) through the discharge port H42 based on the rotation of the rotor unit 30. It may extend to a portion of the discharge unit main body 41, and the first direction protrusion 23 may extend from before the start of the guide surface 411 to a portion of the discharge unit main body 41 past the discharge port H42. there is.

For reference, Figure 9b omits the rotor unit 30 from the formulation discharge unit 2 in order to explain the relationship between the first and second direction protrusions 23 and 24, the guide surface 411, and the discharge port H42. It is an urban city.

As shown in FIG. 9B, the position of the guide surface 411 may overlap the position of the second direction protrusion 24 in the second direction. The inclined direction D1 of the guide surface 411 may be the same as the inclined direction D2 of the lower end of the second direction protrusion 24. For example, the slope of the guide surface 411 and the slope formed at the bottom of the second direction protrusion 24 may be parallel to each other.

At this time, the inclined direction D1 of the guide surface 411 may be inclined toward the discharge port H42, and the inclined direction D2 of the second direction protrusion 24 may be the protrusion length of the second direction protrusion 24. may be in an increasing direction.

Accordingly, when the dosage form located in the seating port 32 of the rotor unit 30 is moved toward the discharge port H42 by the rotation of the rotor unit 30, the dosage form exerts downward pressure by the second direction protrusion 24. Even if it is hit, the formulation is not broken due to the guide surface 411 inclined parallel to the bottom slope of the second direction protrusion 24 and can move toward the discharge port H42 along the slope of the guide surface 411.

The discharge pipe 43 may be a guide pipe that extends downward from the discharge port H42 and guides the formulation discharged through the discharge port H42 to the outside.

The shape of the discharge pipe 43 may be determined depending on the shape of the discharge port H42. In this example, since the discharge port H42 has a square planar shape, the discharge pipe 43 may have a square pillar shape.

In an alternative example, the discharge pipe 43 may be omitted as desired.

The guide surface 411 is a portion connected from a designated portion of the discharge unit main body 41 toward the discharge port H42 as shown in FIG. 3 and may be an inclined surface inclined in a direction sequentially descending toward the discharge port H42. Therefore, the guide surface 411 may be located in a curved shape along the circular discharge unit main body 41 from the boundary between the discharge unit main body 41 and the guide surface 411 to the part where it meets the discharge port H42, Depending on the location, they may be inclined to face different directions.

When the seating port 32 of the rotor unit 30 located at the top of the discharge unit 40 overlaps the guide surface 411 by this guide surface 411, the corresponding formulation located at the seating port 32 is gradually It moves correctly toward the discharge port (H42) along the guide surface (411) and eventually flows normally into the discharge port (H42) and can be discharged to the outside through the discharge pipe (43).

As a result, the formulation located in each seating port 32 moves more accurately and stably toward the discharge port (H42) along the guide surface 411 whose slope increases toward the discharge port (H42), and accurately moves toward the discharge pipe (43). ) so that the discharge operation can be performed.

Because of this, the discharge unit main body 41 can have a flat surface except for the portion where the rotation shaft insertion hole H41, the discharge hole H42, and the guide surface 411 are located.

The edge of the discharge unit main body 41 may have a coupling protrusion 42 that is higher than the surrounding area, so that it can be inserted into the discharge unit coupling groove R22 located at the lower part of the unit main body 20.

In addition, a plurality of coupling protrusions (P42) protruding outward may be located on the outside of the coupling jaw (42), and these coupling protrusions (P42) have corresponding coupling holes (H22) located in the discharge unit coupling groove (R22). It is inserted into so that the coupled state between the discharge part 40 and the unit body 20 can be maintained stably.

As already described, the rotating shaft portion 50 is inserted into the rotating shaft insertion hole H41 located in the center of the discharging portion main body 41 and the rotor cone 311 of the rotor portion 30 located on the discharging portion 40. ), the rotor unit 30 can be rotated in a desired direction.

This rotating shaft portion 50 is connected to a shaft coupling portion (e.g., a second shaft coupling portion) 51 coupled to the rotor portion 30 and a rotating shaft 52 connected to the second shaft coupling portion 51 and connected to the driving unit. ) can be provided.

The second shaft coupling portion 51 may be inserted into the coupling space S311 located at the lower portion of the rotor cone 311 having a cone shape and coupled to the first shaft coupling portion 34.

Accordingly, the second shaft coupling portion 51 also includes a shaft body 511 and a plurality of shaft coupling protrusions (e.g., second shaft coupling protrusions) 512 spaced apart at predetermined intervals on the outside of the shaft main body 511. It can be provided, and a second shaft coupling groove can be formed between two adjacent second shaft coupling protrusions 512.

Accordingly, the assembled formulation discharge unit 2 is coupled to the second shaft coupling portion 51 and can receive the rotational force transmitted from the second shaft coupling portion 51.

The rotation shaft 52 integrally connected to the second shaft coupling portion 51 is a part physically connected to a drive unit equipped with a motor, etc., and the rotation force generated by the operation of the drive unit is transmitted to the rotation shaft 52 and the rotation shaft unit ( 50) can be rotated.

Accordingly, the first shaft coupling portion 34 and the second shaft coupling portion 51 may be coupled to each other by protrusions and grooves, and as a result, the rotating shaft portion 50 is connected to the formulation discharge unit 2, as already described. It can be physically coupled and connected to the rotor part 30 of. Due to the rotation of the rotation shaft unit 50, the rotational force of the rotation shaft unit 50 is transmitted to the rotor unit 30 that is physically connected to the rotation shaft unit 50, so that the rotor unit 30 can also rotate in the corresponding direction. .

Next, referring to FIG. 10, a description will be given of the formulation dispenser 200, which is provided with the formulation dispensing device 100 and automatically discharges a desired formulation by operating the formulation dispensing device 100.

As shown in FIG. 10, the formulation dispensing 200, as an example, includes at least one formulation dispensing device 100 including a formulation cartridge 1 and a formulation discharging unit 2, and the formulation dispensing device 100. It may include a driving unit 201 that drives the rotor unit 30, a control unit 202 connected to the driving unit 201, and a memory 203 connected to the control unit 202.

Each dosage form cartridge 1 of each dosage form discharge device 10 may contain different types of dosage forms, and the user may use a user selection switch to store the type of dosage form desired by the user. ), you can perform a selection operation so that the desired dosage form is discharged.

The driving unit 201 is connected to the rotating shaft 52 of the rotating shaft unit 50 to drive the rotor unit 30 in a set direction and speed, and may be a motor unit equipped with a motor and a motor driving circuit.

The control unit 202 is for operating the driving unit 201 and may be a processor, and the memory 203 may be a storage medium that stores data and programs necessary for driving the formulation dispensing device 100. there is.

Therefore, the control unit 202 performs operations according to the program stored in the memory 203 and operates at a speed and direction determined according to the data (e.g., rotation direction and rotation speed) stored in the memory 203. A signal can be output to the driver 201.

Because of this, the drive unit 201 operates in accordance with the drive signal applied from the control unit 202 to operate the rotation shaft unit 50, thereby rotating the rotor unit 30 at a predetermined speed and direction.

By operating the rotor unit 30, the dosage forms stored in the dosage form cartridge 1 can be discharged one by one at a set speed.

At this time, the formulation dispenser may further include a discharge number detection unit located near the discharge pipe 43 or the discharge port H42 and connected to the control unit 102.

The discharge number detection unit is for detecting the number of formulations falling into the discharge pipe (43) or discharge port (H42) and is equipped with a light emitting part that outputs light and a light receiving part that receives the output light and outputs a signal of the corresponding state. You can. Therefore, the discharge portion 40 may be made of a transparent material that transmits light, such as transparent plastic.

Accordingly, the control unit 202 can count the number of falling formulations using a signal applied from the light receiving unit and control the discharge of the desired number of formulations.

By using the formulation dispenser 100, the user can perform a selection operation using a user selection switch (not shown) so that the formulation dispensing device 100 containing the formulation desired by the user can be operated. .

Accordingly, the control unit 202 controls the operation of the corresponding formulation dispensing device 100 according to the user selection switch, so that the type of formulation desired by the user can be automatically discharged.

This formulation dispenser 200 may be further equipped with an information output unit (e.g., a liquid crystal display or an organic light emitting display device) that outputs additional information. In this case, the operating status of the formulation dispenser 200 (e.g., the current vitamin C is being dispensed) or operation results (e.g., 1 vitamin C tablet has been dispensed) can be output to the information output unit. At this time, information or data necessary for the operation of the information output unit may also be stored in the memory.

The technical features disclosed in each embodiment of the present invention are not limited to the corresponding embodiment, and unless they are incompatible with each other, the technical features disclosed in each embodiment may be combined and applied to other embodiments.

Therefore, in each embodiment, each technical feature is mainly explained, but unless the technical features are incompatible with each other, they can be applied in combination with each other.

The present invention is not limited to the above-described embodiments and the accompanying drawings, and various modifications and variations will be possible from the perspective of those skilled in the art to which the present invention pertains. Therefore, the scope of the present invention should be determined not only by the claims of this specification but also by equivalents to these claims.

100: formulation dispensing device 200: formulation dispenser
1: Formulation cartridge 11: Cartridge body
12: first coupling portion 2: formulation discharge unit
20: Unit body 21: Case
22: second coupling portion 23: first direction projection
24: second direction projection 30: rotor unit
31: rotor body 311: rotor cone
312: edge 32: seating port
33: Second direction protrusion insertion groove
34: first shaft coupling portion 341: side wall
342: First shaft coupling protrusion 40: Discharge portion
41: Discharge body 411: Guide surface
42: coupling jaw 43: discharge pipe
50: Rotating shaft portion 51: Second shaft coupling portion
511: shaft body 512: second shaft coupling protrusion
52: Rotating shaft H22: Coupling hole
H41: Rotating shaft insertion port H42: Discharge port
S11: storage space S20: seating space
S311: Coupling space R21: Rotor coupling groove
R22: Discharge connection groove P42: Connection protrusion

Claims (16)

a formulation cartridge having a formulation located in an internal storage space and having a first coupling portion; and
Formulation discharge unit coupled to the first coupling portion of the formulation cartridge
Including,
The formulation discharge unit is,
It has a second coupling part coupled to the first coupling part, a rotor part coupling groove and a discharge part coupling groove sequentially located at the bottom, and extending in parallel in the first direction from the lower inner surface of the second coupling part. A unit body having a first direction protrusion;
a rotor unit that is mounted and rotated in the rotor unit coupling groove and has a plurality of seating holes; and
A discharge unit mounted on the discharge unit coupling groove, located below the rotor unit, and having a discharge port through which the formulation is discharged.
A formulation dispensing device comprising a. According to claim 1,
A formulation dispensing device in which a gap between the first direction projection and the upper surface of the rotor unit facing the first direction projection at the bottom is smaller than or equal to the minimum diameter and minimum height of the formulation. According to claim 1,
A formulation dispensing device in which the first direction protrusion overlaps by more than 1/2 of the diameter of the seating port located at the bottom. According to claim 1,
A formulation dispensing device in which the width of the first direction protrusion increases toward the dispensing port. According to claim 1,
A formulation dispensing device wherein the first direction protrusion overlaps the discharging port located at the bottom. According to claim 1,
The formulation dispensing device further includes a rotor cone in which the rotor unit is located in a central portion and is surrounded by the seating port. According to claim 1,
The unit body further includes a second direction protrusion protruding from a lower surface of the second coupling portion in a second direction intersecting the first direction. According to clause 7,
The rotor unit is located between two adjacent seating holes and further includes a second direction protrusion insertion groove into which the second direction protrusion is inserted. According to clause 7,
A formulation dispensing device in which the width of the second direction protrusion insertion groove is greater than the width of the second direction protrusion and smaller than the maximum width of the seating port. According to clause 7,
The formulation dispensing device further includes a guide surface that is connected to the discharge port and is inclined toward the discharge port. According to claim 10,
A formulation dispensing device wherein the second direction protrusion overlaps the guide surface and the discharge port located below. According to claim 11,
A formulation dispensing device in which the protruding length of the second direction protrusion increases toward the discharging port. According to clause 6,
A formulation dispensing device wherein the position of the guide surface overlaps the position of the second direction protrusion in the second direction. According to clause 6,
A formulation dispensing device in which the inclination direction of the guide surface is parallel to the inclination direction of the lower end of the second direction protrusion. A formulation dispenser comprising at least one formulation dispensing device of claims 1 to 14. According to claim 15,
a driving unit connected to the formulation dispensing device;
a control unit connected to the driving unit and operating the driving unit; and
A memory connected to the control unit and storing data necessary for the operation of the control unit.
A formulation dispenser further comprising:

Images